Cutera (CUTR) 10-Q 7 Nov 16 2016 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Oct. 31, 2016
Document Information [Line Items]
Entity Registrant Name	CUTERA INC
Entity Central Index Key	1,162,461
Trading Symbol	cutr
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		13,408,087
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Convertible Preferred Stock [Member]
Stockholders’ equity:
Convertible preferred stock, $0.001 par value; authorized: 5,000,000 shares; none issued and outstanding
Cash and cash equivalents	11,275	10,868
Marketable investments	35,108	37,539
Accounts receivable, net	11,680	11,669
Inventories	16,478	12,078
Other current assets and prepaid expenses	2,507	1,675
Total current assets	77,048	73,829
Property and equipment, net	1,720	1,473
Deferred tax asset	410	350
Intangibles, net	16	143
Goodwill	1,339	1,339
Other long-term assets	444	384
Total assets	80,977	77,518
Accounts payable	3,283	1,959
Accrued liabilities	14,786	13,834
Deferred revenue	8,312	8,638
Total current liabilities	26,381	24,431
Deferred revenue, net of current portion	1,426	2,287
Income tax liability	164	182
Other long-term liabilities	597	584
Total liabilities	28,568	27,484
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 13,388,830 and 12,980,807 shares at September 30, 2016 and December 31, 2015, respectively	13	13
Additional paid-in capital	83,758	79,782
Accumulated deficit	(31,308)	(29,672)
Accumulated other comprehensive loss	(54)	(89)
Total stockholders’ equity	52,409	50,034
Total liabilities and stockholders’ equity	$ 80,977	$ 77,518

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Convertible Preferred Stock [Member]
Convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, authorized (in shares)	5,000,000	5,000,000
Convertible preferred stock, issued (in shares)	0	0
Convertible preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	13,388,830	12,980,807
Common stock, outstanding (in shares)	13,388,830	12,980,807

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net revenue:
Products	$ 25,493,000	$ 18,797,000	$ 65,903,000	$ 51,542,000
Service	4,788,000	4,288,000	14,278,000	13,177,000
Total net revenue	30,281,000	23,085,000	80,181,000	64,719,000
Cost of revenue:
Products	10,160,000	7,625,000	26,804,000	22,555,000
Service	2,378,000	1,969,000	7,155,000	5,778,000
Total cost of revenue	12,538,000	9,594,000	33,959,000	28,333,000
Gross profit	17,743,000	13,491,000	46,222,000	36,386,000
Operating expenses:
Sales and marketing	10,574,000	8,790,000	30,002,000	26,043,000
Research and development	2,914,000	2,748,000	8,335,000	7,921,000
General and administrative	2,716,000	2,937,000	9,933,000	8,940,000
Total operating expenses	16,204,000	14,475,000	48,270,000	42,904,000
Income (loss) from operations	1,539,000	(984,000)	(2,048,000)	(6,518,000)
Interest and other income, net	166,000	84,000	527,000	188,000
Income (loss) before income taxes	1,705,000	(900,000)	(1,521,000)	(6,330,000)
Provision for income taxes	61,000	57,000	115,000	160,000
Net income (loss)	$ 1,644,000	$ (957,000)	$ (1,636,000)	$ (6,490,000)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.12	$ (0.07)	$ (0.12)	$ (0.45)
Diluted (in dollars per share)	$ 0.12	$ (0.07)	$ (0.12)	$ (0.45)
Weighted-average number of shares used in per share calculations:
Basic (in shares)	13,163	13,827	13,102	14,290
Diluted (in shares)	13,544	13,827	13,102	14,290

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net loss	$ 1,644	$ (957)	$ (1,636)	$ (6,490)
Available-for-sale investments
Net change in unrealized gain (loss) on available-for-sale investments	(24)	(19)	56	1
Less: Reclassification adjustment for gains on investments recognized during the year	(1)	(4)	(1)	(6)
Net change in unrealized gain (loss) on available-for-sale investments	(25)	(23)	55	(5)
Tax provision (benefit)	(9)	(6)	20
Other comprehensive income (loss), net of tax	(16)	(17)	35	(5)
Comprehensive income (loss)	$ 1,628	$ (974)	$ (1,601)	$ (6,495)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (1,636)	$ (6,490)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	2,652	2,987
Depreciation and amortization	733	912
Other	(45)	213
Changes in assets and liabilities:
Accounts receivable	(61)	2,124
Inventories	(4,400)	(2,491)
Other current assets and prepaid expenses	(690)	(138)
Other long-term assets	(60)	(31)
Accounts payable	1,324	(424)
Accrued liabilities	886	544
Other long-term liabilities	(247)	(217)
Deferred revenue	(1,187)	(2,279)
Income tax liability	(18)	42
Net cash used in operating activities	(2,749)	(5,248)
Cash flows from investing activities:
Acquisition of property, equipment and software	(311)	(703)
Disposal of property and equipment	17
Proceeds from sales of marketable investments	6,153	19,271
Proceeds from maturities of marketable investments	20,135	29,024
Purchase of marketable investments	(23,944)	(14,887)
Net cash provided by investing activities	2,050	32,705
Cash flows from financing activities:
Repurchase of common stock	(4,873)	(36,616)
Proceeds from exercise of stock options and employee stock purchase plan	6,197	9,554
Payments on capital lease obligations	(218)	(143)
Net cash provided by (used in) financing activities	1,106	(27,205)
Net increase in cash and cash equivalents	407	252
Cash and cash equivalents at beginning of period	10,868	9,803
Cash and cash equivalents at end of period	11,275	10,055
Supplemental disclosure of non-cash items:
Repurchase of common stock acquired but not settled		604
Assets acquired under capital lease	$ 580	$ 51

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	Note 1. Summary of Significant Accounting Policies Description of Operations and Principles of Consolidation Cutera, Inc. (“Cutera” or the “Company”) is a global provider of laser and other energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, and markets laser and other energy-based product platforms for use by physicians and other qualified practitioners which enable them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following key system platforms: en lighten TM , excel HR TM , truSculpt TM , excel V TM , and xeo ® . Titan ® truSculpt Titan truSculpt Headquartered in Brisbane, California, the Company has wholly-owned subsidiaries that are currently operational in Australia, Belgium, Canada, France, Hong Kong, Japan , Spain , Switzerland and the United Kingdom. These subsidiaries market, sell and service the Company’s products outside of the United States. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated. Unaudited Interim Financial Information The interim financial information filed is unaudited. The Condensed Consolidated Financial Statements included in this report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for the fair statement of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The December 31, 2015 Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The results for interim periods are not necessarily indicative of the results for the entire year or any other interim period. The Condensed Consolidated Financial Statements should be read in conjunction with the Company’s previously filed audited financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2016. Use of Estimates The preparation of interim Condensed Consolidated Financial Statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported and disclosed in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates these estimates, including those related to revenue elements, warranty obligations, sales commissions, accounts receivable and sales allowances, provision for excess and obsolete inventories, fair values of marketable investments, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of performance stock units and options to purchase the Company’s stock, recoverability of deferred tax assets, legal matters and claims, and effective income tax rates, among others. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases

Note 2 - Cash, Cash Equivalents

Note 2 - Cash, Cash Equivalents and Marketable Investments	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Cash, Cash Equivalents, and Marketable Securities [Text Block]	Note 2. Cash , Cash Equivalents and Marketable Investments The Company invests its cash primarily in money market funds, commercial paper, corporate notes and bonds, municipal bonds, and debt securities issued by the U.S. government and its agencies. The Company considers all highly liquid investments, with an original maturity of three months or less at the time of purchase, to be cash equivalents. Investments with maturities of greater than three months at the time of purchase are accounted for as “available-for-sale ,” are carried at fair value with unrealized gains and losses reported as a component of stockholders’ equity, are held for use in current operations and are classified in current assets as “marketable investments .” The following tables summarize the components, and the unrealized gains and losses position, related to the Company’s cash, cash equivalents and marketable investments (in thousands): September 30, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 8,540 $ — $ — $ 8,540 Money market funds 35 — — 35 Commercial paper 2,700 — — 2,700 Total cash and cash equivalents 11,275 — — 11,275 Marketable investments: U.S. government notes 9,670 12 — 9,682 U.S. government agencies 3,912 — — 3,912 Municipal securities 2,753 2 — 2,755 Commercial paper 7,475 3 (1 ) 7,477 Corporate debt securities 11,282 4 (4 ) 11,282 Total marketable investments 35,092 21 (5 ) 35,108 Total cash, cash equivalents and marketable investments $ 46,367 $ 21 $ (5 ) $ 46,383 December 31, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 9,830 $ — $ — $ 9,830 Money market funds 1,000 — — 1,000 Commercial paper 38 — — 38 Total cash and cash equivalents 10,868 — — 10,868 Marketable investments: U.S. government notes 7,780 1 (2 ) 7,779 U.S. government agencies 12,630 3 (25 ) 12,608 Municipal securities 4,344 2 — 4,346 Commercial paper 4,041 1 (2 ) 4,040 Corporate debt securities 8,783 — (17 ) 8,766 Total marketable investments 37,578 7 (46 ) 37,539 Total cash, cash equivalents and marketable investments $ 48,446 $ 7 $ (46 ) $ 48,407 As of September 30, 2016 and December 31, 2015, total gross unrealized losses were $5 ,000 and $46,000, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months . The following table summarizes the contractual maturities of the Company’s available-for-sale securities, classified as marketable investments as of September 30, 2016 (in thousands): Amount Due in less than one year $ 28,414 Due in 1 to 3 years 6,694 Total marketable investments $ 35,108

Note 3 - Fair Value of Financia

Note 3 - Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 3. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) unobservable inputs (Level 1) (Level 3). ● Level 1: ● Level 2: ● Level 3: In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. As of September 30, 2016, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands): September 30, 2016 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 35 $ — $ — $ 35 Commercial paper — 2,700 — 2,700 Marketable investments: Available-for-sale securities — 35,108 — 35,108 Total assets at fair value $ 35 $ 37,808 $ — $ 37,843 As of December 31, 2015, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above was as follows (in thousands): December 31, 2015 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,000 $ — $ — $ 1,000 Commercial paper — 38 — 38 Marketable investments: Available-for-sale securities — 37,539 — 37,539 Total assets at fair value $ 1,000 $ 37,577 $ — $ 38,577 The Company’s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The weighted average remaining maturity of the Company’s Level 2 investments as of September 30, 2016 is less than 1 year and all of these investments are rated by S&P and Moody’s at A or better .

Note 4 - Balance Sheet Details

Note 4 - Balance Sheet Details	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	Note 4. Balance Sheet Details Inventories As of September 30, 2016 and December 31, 2015, inventories consist of the following (in thousands): September 3 0 , 201 6 December 31, 201 5 Raw materials $ 10,889 $ 7,982 Finished goods 5,589 4,096 Total $ 16,478 $ 12,078 Accrued Liabilities As of September 30, 2016 and December 31, 2015, accrued liabilities consist of the following (in thousands): September 3 0 , 201 6 December 31, 201 5 Accrued payroll and related expenses $ 7,865 $ 7,726 Warranty liability 2,100 1,819 Sales tax 1,735 1,935 Other 3,086 2,354 Total $ 14,786 $ 13,834

Note 5 - Warranty

Note 5 - Warranty	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Product Warranty Disclosure [Text Block]	Note 5. Warranty The Company provides a standard one-year warranty on all systems . For direct sales to end customers, warranty coverage provided is for labor and parts necessary to repair the systems during the warranty period. For sales to distributors, we provide a 14 to 16 month warranty for parts only. The distributor provides the labor to their end customer. The Company has a direct field service organization in the U.S. Internationally, the Company provides direct service support through its wholly-owned subsidiaries in Australia, Belgium, Canada, France , Hong Kong, Spain, Japan , Switzerland and the United Kingdom. In several other countries where it does not have a direct presence, the Company provides service through a network of distributors and third-party service providers. After the original warranty period, maintenance and support are offered on a service contract basis or on a time and materials basis. The Company provides for the estimated cost to repair or replace products under warranty at the time of sale. The following table provides the changes in the product warranty accrual for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Beginning Balance $ 2,000 $ 1,254 $ 1,819 $ 1,167 Add: Accruals for warranties issued during the period 1,202 1,122 3,634 2,674 Less: Settlements made during the period (1,102 ) (979 ) (3,353 ) (2,444 ) Ending Balance $ 2,100 $ 1,397 $ 2,100 $ 1,397

Note 6 - Deferred Service Contr

Note 6 - Deferred Service Contract Revenue	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Deferred Revenue Disclosure [Text Block]	Note 6. Deferred Service Contract Revenue The Company generates Service revenue from the sale of extended service contracts and from time and material services provided to customers who are not under a warranty or extended service contract. Service contract revenue is recognized on a straight-line basis over the period of the applicable contract. Service revenue, from customers whose systems are not under a service contract, is recognized as the services are provided. The following table provides changes in the deferred service contract revenue balance for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Beginning Balance $ 10,223 $ 11,546 $ 10,469 $ 12,949 Add: Payments received 2,517 2,331 8,825 7,383 Less: Revenue recognized (3,447 ) (3,199 ) (10,001 ) (9,654 ) Ending Balance $ 9,293 $ 10,678 $ 9,293 $ 10,678 Costs for extended service contracts were $1.7 million and $1.5 million for the three months ended September 30, 2016 and 2015, respectively, and $4.9 million and $4.6 million for the nine months ended September 30, 2016 and 2015, respectively.

Note 7 - Stockholders' Equity a

Note 7 - Stockholders' Equity and Stock-based Compensation Expense	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7. Stockholders’ Equity and Stock-based Compensation Expense Share Repurchase Program On February 8, 2016, the Company announced that its Board of Directors approved the expansion of its Stock Repurchase Program by $10 million, under which the Company is authorized to repurchase shares of its common stock. In the three months ended September 3 0, 2016, the Company repurchased 176,493 shares of its common stock for approximately $1.9 million . In the nine months ended September 3 0, 2016, the Company repurchased 455,311 shares of its common stock for approximately $4.9 million . As of September 30, 2016, there remained an additional $5.1 million available in the Stock Repurchase Program to repurchase shares of common stock. All shares repurchased were retired and returned to authorized but unissued status. Stock-based Compensation Expense Stock-based compensation expense by department recognized during the three and nine months ended September 30, 2016 and 2015 were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Cost of revenue $ 73 $ 112 $ 254 $ 329 Sales and marketing 239 311 844 727 Research and development 131 148 416 510 General and administrative 127 473 1,138 1,421 Total stock-based compensation expense $ 570 $ 1,044 $ 2,652 $ 2,987 Activity under the Company’s 2004 Equity Incentive Plan, as amended, is summarized as follows: Options Outstanding Shares Available for Grant Number of Stock Options Outstanding Weighted- Average Exercise Price Balance, December 31, 2015 1,263,425 2,148,797 $ 9.31 Options granted (141,500 ) 141,500 11.28 Stock awards granted ( 1) (2) (925,675 ) — — Options exercised — (706,522 ) 9.05 Options canceled 122,373 (122,373 ) 13.19 Stock awards canceled ( 1) 493,858 — — Balance, September 30, 2016 812,481 1,461,402 $ 9.29 (1) The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan requires the subtraction or add back of 2.12 shares from or to the Shares Available for Grant, respectively. (2) Included in 'Stock awards granted' of 925,675 , was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be released on March 15, 201 7 , based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8 , 201 6 . Under the 2004 Equity Incentive Plan, as amended, the Company issued 425,838 shares and 876,387 shares of common stock during the three and nine months ended September 30, 2016 , respectively, in conjunction with stock options exercised and the vesting of RSUs and PSUs . As of September 30, 2016, there was approximately $3.4 million of unrecognized compensation expense, net of projected forfeitures, related to non-vested equity awards. The expense is expected to be recognized over the remaining weighted-average period of 1.85 years. The actual expense recorded in the future may be higher or lower based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.

Note 8 - Net Loss Per Share

Note 8 - Net Loss Per Share	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 8. Net Income ( Loss ) Per Share Basic net income (loss) per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the year. Diluted net income (loss) per common share is the same as basic net income (loss) per common share, as the effect of the potential common stock equivalents is anti-dilutive and as such is excluded from the calculations of the diluted net loss per share. The following numbers of shares outstanding, prior to the application of the treasury stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 201 6 201 5 201 6 201 5 Options to purchase common stock 1,740 2,330 1,952 2,710 Restricted stock units 334 307 395 296 Performance stock units 64 — 81 96 Employee stock purchase plan shares 40 27 83 59 Total 2,178 2,664 2,511 3,161

Note 9 - Income Taxes

Note 9 - Income Taxes	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 9. Income Taxes The Company historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pretax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. When applicable, the year-to-date tax provision reflects adjustments from discrete tax items. However, for the fiscal three- and nine-month periods ended September 30, 2016, the Company used a discrete effective tax rate method to calculate the provision for income taxes. The Company determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the fiscal three- and nine-month periods ended September 30, 2016. The Company’s income tax provision for the three and nine months ended September 3 0, 2016 and 2015 relates primarily to income taxes of the Company’s non-U.S. operations. The Company’s U.S. operation continue to be in a loss position and the Company maintains a 100% valuation allowance against its U.S. deferred tax assets. For the three and nine months ended September 3 0, 2016, the Company’s income tax provision was $61,000 and $115,000, compared to $57,000 and $160,000 for the same periods in 2015, respectively. The income tax provision includes certain discrete tax items recorded in the reporting periods . The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. As of September 30, 2016, and December 31, 2015, the Company had a 100% valuation allowance against its U.S. deferred tax assets. Significant management judgment is required in determining any valuation allowance recorded against deferred tax assets. In evaluating the ability to recover deferred tax assets, the Company considered available positive and negative evidence giving greater weight to its recent cumulative losses and lesser weight to its projected financial results due to the subjectivity involved in forecasting future periods. The Company also c onsidered, commensurate with its objective verifiability, the forecast of future taxable income including the reversal of temporary differences and the implementation of feasible and prudent tax planning strategies.

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 10. Commitments and Contingencies The Company is named from time to time as a party to product liability, contractual lawsuits and other general corporate matters in the normal course of business. The Company routinely assesses the likelihood of any adverse judgments or outcomes related to legal matters and claims, as well as ranges of probable losses. A determination of the amount of the reserves required, if any, for these contingencies is made after analysis of each known issue, historical experience, whether it is more likely than not that the Company shall incur a loss, and whether the loss is estimable. The Company is not currently a party to any material legal proceedings.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	Description of Operations and Principles of Consolidation Cutera, Inc. (“Cutera” or the “Company”) is a global provider of laser and other energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, and markets laser and other energy-based product platforms for use by physicians and other qualified practitioners which enable them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following key system platforms: en lighten TM , excel HR TM , truSculpt TM , excel V TM , and xeo ® . Titan ® truSculpt Titan truSculpt Headquartered in Brisbane, California, the Company has wholly-owned subsidiaries that are currently operational in Australia, Belgium, Canada, France, Hong Kong, Japan , Spain , Switzerland and the United Kingdom. These subsidiaries market, sell and service the Company’s products outside of the United States. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.
Unaudited Interim Financial Information [Policy Text Block]	Unaudited Interim Financial Information The interim financial information filed is unaudited. The Condensed Consolidated Financial Statements included in this report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for the fair statement of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The December 31, 2015 Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The results for interim periods are not necessarily indicative of the results for the entire year or any other interim period. The Condensed Consolidated Financial Statements should be read in conjunction with the Company’s previously filed audited financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2016.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of interim Condensed Consolidated Financial Statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported and disclosed in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates these estimates, including those related to revenue elements, warranty obligations, sales commissions, accounts receivable and sales allowances, provision for excess and obsolete inventories, fair values of marketable investments, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of performance stock units and options to purchase the Company’s stock, recoverability of deferred tax assets, legal matters and claims, and effective income tax rates, among others. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases

Note 2 - Cash, Cash Equivalen18

Note 2 - Cash, Cash Equivalents and Marketable Investments (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Unrealized Gain (Loss) on Investments [Table Text Block]	September 30, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 8,540 $ — $ — $ 8,540 Money market funds 35 — — 35 Commercial paper 2,700 — — 2,700 Total cash and cash equivalents 11,275 — — 11,275 Marketable investments: U.S. government notes 9,670 12 — 9,682 U.S. government agencies 3,912 — — 3,912 Municipal securities 2,753 2 — 2,755 Commercial paper 7,475 3 (1 ) 7,477 Corporate debt securities 11,282 4 (4 ) 11,282 Total marketable investments 35,092 21 (5 ) 35,108 Total cash, cash equivalents and marketable investments $ 46,367 $ 21 $ (5 ) $ 46,383 December 31, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 9,830 $ — $ — $ 9,830 Money market funds 1,000 — — 1,000 Commercial paper 38 — — 38 Total cash and cash equivalents 10,868 — — 10,868 Marketable investments: U.S. government notes 7,780 1 (2 ) 7,779 U.S. government agencies 12,630 3 (25 ) 12,608 Municipal securities 4,344 2 — 4,346 Commercial paper 4,041 1 (2 ) 4,040 Corporate debt securities 8,783 — (17 ) 8,766 Total marketable investments 37,578 7 (46 ) 37,539 Total cash, cash equivalents and marketable investments $ 48,446 $ 7 $ (46 ) $ 48,407
Investments Classified by Contractual Maturity Date [Table Text Block]	Amount Due in less than one year $ 28,414 Due in 1 to 3 years 6,694 Total marketable investments $ 35,108

Note 3 - Fair Value of Financ19

Note 3 - Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	September 30, 2016 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 35 $ — $ — $ 35 Commercial paper — 2,700 — 2,700 Marketable investments: Available-for-sale securities — 35,108 — 35,108 Total assets at fair value $ 35 $ 37,808 $ — $ 37,843 December 31, 2015 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,000 $ — $ — $ 1,000 Commercial paper — 38 — 38 Marketable investments: Available-for-sale securities — 37,539 — 37,539 Total assets at fair value $ 1,000 $ 37,577 $ — $ 38,577

Note 4 - Balance Sheet Details

Note 4 - Balance Sheet Details (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 3 0 , 201 6 December 31, 201 5 Raw materials $ 10,889 $ 7,982 Finished goods 5,589 4,096 Total $ 16,478 $ 12,078
Schedule of Accrued Liabilities [Table Text Block]	September 3 0 , 201 6 December 31, 201 5 Accrued payroll and related expenses $ 7,865 $ 7,726 Warranty liability 2,100 1,819 Sales tax 1,735 1,935 Other 3,086 2,354 Total $ 14,786 $ 13,834

Note 5 - Warranty (Tables)

Note 5 - Warranty (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Product Warranty Liability [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Beginning Balance $ 2,000 $ 1,254 $ 1,819 $ 1,167 Add: Accruals for warranties issued during the period 1,202 1,122 3,634 2,674 Less: Settlements made during the period (1,102 ) (979 ) (3,353 ) (2,444 ) Ending Balance $ 2,100 $ 1,397 $ 2,100 $ 1,397

Note 6 - Deferred Service Con22

Note 6 - Deferred Service Contract Revenue (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Beginning Balance $ 10,223 $ 11,546 $ 10,469 $ 12,949 Add: Payments received 2,517 2,331 8,825 7,383 Less: Revenue recognized (3,447 ) (3,199 ) (10,001 ) (9,654 ) Ending Balance $ 9,293 $ 10,678 $ 9,293 $ 10,678

Note 7 - Stockholders' Equity23

Note 7 - Stockholders' Equity and Stock-based Compensation Expense (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Cost of revenue $ 73 $ 112 $ 254 $ 329 Sales and marketing 239 311 844 727 Research and development 131 148 416 510 General and administrative 127 473 1,138 1,421 Total stock-based compensation expense $ 570 $ 1,044 $ 2,652 $ 2,987
Schedule of Share-based Compensation, Activity [Table Text Block]	Options Outstanding Shares Available for Grant Number of Stock Options Outstanding Weighted- Average Exercise Price Balance, December 31, 2015 1,263,425 2,148,797 $ 9.31 Options granted (141,500 ) 141,500 11.28 Stock awards granted ( 1) (2) (925,675 ) — — Options exercised — (706,522 ) 9.05 Options canceled 122,373 (122,373 ) 13.19 Stock awards canceled ( 1) 493,858 — — Balance, September 30, 2016 812,481 1,461,402 $ 9.29

Note 8 - Net Loss Per Share (Ta

Note 8 - Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 201 6 201 5 201 6 201 5 Options to purchase common stock 1,740 2,330 1,952 2,710 Restricted stock units 334 307 395 296 Performance stock units 64 — 81 96 Employee stock purchase plan shares 40 27 83 59 Total 2,178 2,664 2,511 3,161

Note 2 - Cash, Cash Equivalen25

Note 2 - Cash, Cash Equivalents and Marketable Investments (Details Textual) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	$ 0
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax	$ 5,000	$ 46,000

Note 2 - Cash, Cash Equivalen26

Note 2 - Cash, Cash Equivalents and Marketable Investments - Unrealized Gains and Losses Related to Marketable Investments (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Cash [Member]
Amortized Cost	$ 8,540,000	$ 9,830,000
Fair Market Value	8,540,000	9,830,000
Money Market Funds [Member]
Amortized Cost	35,000	1,000,000
Fair Market Value	35,000	1,000,000
Commercial Paper [Member]
Amortized Cost	2,700,000	38,000
Fair Market Value	2,700,000	38,000
US Treasury and Government [Member]
Amortized Cost	9,670,000	7,780,000
Gross Unrealized Gains	12,000	1,000
Fair Market Value	9,682,000	7,779,000
Gross Unrealized Losses		(2,000)
US Government Agencies Debt Securities [Member]
Amortized Cost	3,912,000	12,630,000
Gross Unrealized Gains		3,000
Fair Market Value	3,912,000	12,608,000
Gross Unrealized Losses		(25,000)
US States and Political Subdivisions Debt Securities [Member]
Amortized Cost	2,753,000	4,344,000
Gross Unrealized Gains	2,000	2,000
Fair Market Value	2,755,000	4,346,000
Commercial Paper, Not Included with Cash and Cash Equivalents [Member]
Amortized Cost	7,475,000	4,041,000
Gross Unrealized Gains	3,000	1,000
Fair Market Value	7,477,000	4,040,000
Gross Unrealized Losses	(1,000)	(2,000)
Corporate Debt Securities [Member]
Amortized Cost	11,282,000	8,783,000
Gross Unrealized Gains	4,000
Fair Market Value	11,282,000	8,766,000
Gross Unrealized Losses	(4,000)	(17,000)
Amortized Cost	11,275,000	10,868,000	$ 10,055,000	$ 9,803,000
Fair Market Value	11,275,000	10,868,000
Amortized Cost	35,092,000	37,578,000
Gross Unrealized Gains	21,000	7,000
Fair Market Value	35,108,000	37,539,000
Gross Unrealized Losses	(5,000)	(46,000)
Amortized Cost	46,367,000	48,446,000
Fair Market Value	$ 46,383,000	$ 48,407,000

Note 2 - Cash, Cash Equivalen27

Note 2 - Cash, Cash Equivalents and Marketable Investments - Maturities of Available-for-Sale Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Due in less than one year	$ 28,414
Due in 1 to 3 years	6,694
Total marketable investments	$ 35,108	$ 37,539

Note 3 - Fair Value of Financ28

Note 3 - Fair Value of Financial Instruments (Details Textual)	9 Months Ended
	Sep. 30, 2016
Maximum Maturity Period Of Investments	1 year

Note 3 - Fair Value of Financ29

Note 3 - Fair Value of Financial Instruments- Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents:
Cash Equivalents	$ 35	$ 1,000
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member]
Cash equivalents:
Cash Equivalents	35	1,000
Fair Value, Measurements, Recurring [Member] | Commercial Paper [Member] | Fair Value, Inputs, Level 2 [Member]
Cash equivalents:
Cash Equivalents	2,700	38
Fair Value, Measurements, Recurring [Member] | Commercial Paper [Member]
Cash equivalents:
Cash Equivalents	2,700	38
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Marketable investments:
Total assets at fair value	35	1,000
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Marketable investments:
Available-for-sale securities	35,108	37,539
Total assets at fair value	37,808	37,577
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Marketable investments:
Total assets at fair value
Fair Value, Measurements, Recurring [Member]
Marketable investments:
Available-for-sale securities	35,108	37,539
Total assets at fair value	37,843	38,577
Money Market Funds [Member]
Cash equivalents:
Cash Equivalents	35	1,000
Commercial Paper [Member]
Cash equivalents:
Cash Equivalents	2,700	38
Cash Equivalents	11,275	10,868
Marketable investments:
Available-for-sale securities	$ 35,108	$ 37,539

Note 4 - Balance Sheet Detail30

Note 4 - Balance Sheet Details - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Raw materials	$ 10,889	$ 7,982
Finished goods	5,589	4,096
Total	$ 16,478	$ 12,078

Note 4 - Balance Sheet Detail31

Note 4 - Balance Sheet Details - Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Accrued payroll and related expenses	$ 7,865	$ 7,726
Warranty liability	2,100	1,819
Sales tax	1,735	1,935
Other	3,086	2,354
Total	$ 14,786	$ 13,834

Note 5 - Warranty - Summary of

Note 5 - Warranty - Summary of Warranties (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Beginning Balance	$ 2,000	$ 1,254	$ 1,819	$ 1,167
Add: Accruals for warranties issued during the period	1,202	1,122	3,634	2,674
Less: Settlements made during the period	(1,102)	(979)	(3,353)	(2,444)
Ending Balance	$ 2,100	$ 1,397	$ 2,100	$ 1,397

Note 6 - Deferred Service Con33

Note 6 - Deferred Service Contract Revenue (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Deferred Revenue Costs Incurred	$ 1.7	$ 1.5	$ 4.9	$ 4.6

Note 6 - Deferred Service Con34

Note 6 - Deferred Service Contract Revenue - Summary of Deferred Service Contract Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Beginning Balance, deferred service contract revenue	$ 10,223	$ 11,546	$ 10,469	$ 12,949
Add: Payments received	2,517	2,331	8,825	7,383
Less: Revenue recognized	(3,447)	(3,199)	(10,001)	(9,654)
Ending Balance, deferred service contract revenue	$ 9,293	$ 10,678	$ 9,293	$ 10,678

Note 7 - Stockholders' Equity35

Note 7 - Stockholders' Equity and Stock-based Compensation Expense (Details Textual) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
		Sep. 30, 2016	Sep. 30, 2016	Feb. 08, 2016
Modified Stock Buyback Program [Member]
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 5.1	$ 5.1	$ 10
Stock Repurchased During Period, Shares		176,493	455,311
Treasury Stock, Value, Acquired, Cost Method		$ 1.9	$ 4.9
Two Thousand Four Equity Incentive Plan [Member] | Fungible Shares [Member]
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross			416,474
Two Thousand Four Equity Incentive Plan [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted			196,450
Two Thousand Four Equity Incentive Plan [Member]
Number of Stock Awards Counted for Every Share Granted or Canceled			2.12
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross			925,675
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period		425,838	876,387
Employee Stock Option [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 3.4	$ 3.4
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 310 days
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross	[1],[2]		925,675
[1]	Included in 'Stock awards granted' of 925,675, was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be released on March 15, 2017, based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8, 2016.
[2]	The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan requires the subtraction or add back of 2.12 shares from or to the Shares Available for Grant, respectively.

Note 7 - Stockholders' Equity36

Note 7 - Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Cost of Sales [Member]
Allocated Share Based Compensation Expense	$ 73	$ 112	$ 254	$ 329
Selling and Marketing Expense [Member]
Allocated Share Based Compensation Expense	239	311	844	727
Research and Development Expense [Member]
Allocated Share Based Compensation Expense	131	148	416	510
General and Administrative Expense [Member]
Allocated Share Based Compensation Expense	127	473	1,138	1,421
Allocated Share Based Compensation Expense	$ 570	$ 1,044	$ 2,652	$ 2,987

Note 7 - Stockholders' Equity37

Note 7 - Stockholders' Equity and Stock-based Compensation Expense - Activity Under the 2004 Equiy Incentive Plan (Details)	9 Months Ended
	Sep. 30, 2016$ / sharesshares
Balance, shares available for grant (in shares)	1,263,425
Balance, stock options outstanding (in shares)	2,148,797
Balance, weighted-average exercise price (in dollars per share) | $ / shares	$ 9.31
Options granted, shares available for grant (in shares)	(141,500)
Options granted, stock options outstanding (in shares)	141,500
Options granted, weighted-average exercise price (in dollars per share) | $ / shares	$ 11.28
Stock awards granted(1) (2) (in shares)	(925,675)	[1],[2]
Options exercised, stock options outstanding (in shares)	(706,522)
Options exercised, weighted-average exercise price (in dollars per share) | $ / shares	$ 9.05
Options canceled, shares available for grant (in shares)	122,373
Options canceled, stock options outstanding (in shares)	(122,373)
Options canceled, weighted-average exercise price (in dollars per share) | $ / shares	$ 13.19
Stock awards canceled(1) (in shares)	493,858	[2]
Balance, shares available for grant (in shares)	812,481
Balance, stock options outstanding (in shares)	1,461,402
Balance, weighted-average exercise price (in dollars per share) | $ / shares	$ 9.29
[1]	Included in 'Stock awards granted' of 925,675, was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be released on March 15, 2017, based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8, 2016.
[2]	The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan requires the subtraction or add back of 2.12 shares from or to the Shares Available for Grant, respectively.

Note 8 - Net Loss Per Share - A

Note 8 - Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Employee Stock Option [Member]
Antidilutive Securities (in shares)	1,740	2,330	1,952	2,710
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares)	334	307	395	296
Performance Shares [Member]
Antidilutive Securities (in shares)	64		81	96
ESPP [Member]
Antidilutive Securities (in shares)	40	27	83	59
Antidilutive Securities (in shares)	2,178	2,664	2,511	3,161

Note 9 - Income Taxes (Details

Note 9 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Deferred Tax Assets Valuation Allowance Percentage			100.00%		100.00%
Income Tax Expense (Benefit)	$ 61,000	$ 57,000	$ 115,000	$ 160,000